Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement

Yahoo Finance Published Updated Economy
Sign in to save

Why it matters

Adial Pharmaceuticals will implement a 1-for-25 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, with trading adjusted on February 6, 2026.

Expected market reaction

Neutral Confidence 80% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on neutral sentiment with 80% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
AI inference Neutral · 80%
Generated 2026-02-03 21:05

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
41133

Original source

Common Stock Will Begin Trading on Split-Adjusted Basis on February 6, 2026GLEN ALLEN, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will effect a 1-for-25 reverse stock split (the “Reverse Split”) of its common stock, par value $0.001 per share (“Common Stock”), that

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on February 4, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage